Oxoid Salmonella 9-0 Recall - Remel/Thermo Fisher Scientific

ANSM Drug & Device Safety Alerts

Published March 31st, 2026

Detected March 31st, 2026

Summary

ANSM issued safety notice R2608613 informing medical biology laboratories of a field safety corrective action by Remel/Thermo Fisher Scientific, involving the recall of 847 units of Oxoid Salmonella agglutinating sera (Salmonella 9-0). Affected users received a direct communication from Thermo Fisher Scientific with instructions. Laboratories should verify their inventory for affected lots and contact the manufacturer directly.

View original document View source feed page

What changed

ANSM recorded field safety corrective action R2608613 involving Remel/Thermo Fisher Scientific and the recall of 847 units of Oxoid Salmonella agglutinating sera (Salmonella 9-0). The notice references a manufacturer letter dated 31/03/2026 providing further details on the affected lots. ANSM directed inquiries to the issuing company directly.

Medical biology laboratories that may hold affected units of Oxoid Salmonella 9-0 agglutinating sera should immediately review the manufacturer correspondence attached to this notice, verify their inventory for impacted lots, discontinue use of any recalled product, and contact Remel/Thermo Fisher Scientific to arrange return or replacement per the instructions provided.

What to do next

Review the attached Thermo Fisher Scientific letter (dated 31/03/2026) for affected lot numbers
Verify inventory for recalled Oxoid Salmonella 9-0 agglutinating sera units
Contact Remel/Thermo Fisher Scientific directly to coordinate product return or replacement

Source document (simplified)

A+ A-

Rappel n° R2608613 destiné aux laboratoires d'analyses de biologie médicale L'ANSM a été informée de la mise en œuvre du retrait de plusieurs lots effectué par la société Remel / Thermo Fisher Scientific.
Les utilisateurs concernés ont reçu le courrier ci-joint.

Cette action de sécurité est enregistrée à l’ANSM sous le n° R2608613.
Pour toute question, merci de vous adresser directement à l’émetteur de l’action de sécurité. Consultez le courrier de la société Thermo Fisher Scientific (31/03/2026)